The world’s first personalized mRNA cancer immunotherapy for melanoma – the most serious form of skin cancer – is underway in London. According to the American Cancer Society, about 100,000 new melanomas are diagnosed per year in the US.). Around 8,000 Americans die of melanoma every year. However, rates are falling. Artificial intelligence put to work on groundbreaking new melanoma jabMedical journal The Lancet recently published the results of a study into the use of mRNA-based technology to help treat melanoma patients. Moderna, based in Cambridge, Massachusetts, and Merck Sharp and Dohme (…